‘Could This Be COVID-19?’ A Seattle Doctor on the Frontlines
Inside, as usual, patient beds are near capacity, and the emergency department is filled with not only the usual mix ...
These articles also appear in the Global Biodefense Magazine – 24 March 2020 edition.
Inside, as usual, patient beds are near capacity, and the emergency department is filled with not only the usual mix ...
In order to determine the spectrum of disease in children, researchers evaluated children infected with SARS-CoV-2 and treated at the ...
Certain aspects of the pathogenesis of SARS-CoV-2 can only be studied in detail in animal models, where repeated sampling and ...
Investors are looking at big losses in two “pandemic bonds,” issued by the World Bank’s International Bank for Reconstruction and Development ...
At the White House briefing Wednesday on efforts to combat COVID-19, Defense Secretary Mark Esper said that he had just ...
Approximately 500,000 testing swabs and supplies were flown by Air Mobility Command on March 19-20 from Aviano Air Base, Italy, ...
First Rapid, Point-of-Care and Near-Patient Molecular Test for Detection of Virus that Causes COVID-19 Cepheid today announced it has received ...
SARS-CoV-2 – the coronavirus that causes the disease COVID-19 – is completely new and attacks cells in a novel way. ...
Last week, Florida health officials found themselves overwhelmed. The state’s disease experts were working around the clock to trace the ...
Ventec Life Systems and GM in cooperation with StopTheSpread.org, the nation's coordinated private sector response to the COVID-19, are collaborating ...
If the US forgoes contact tracing in favour of aggressive social-distancing measures alone, the country risks the outbreak worsening, and ...
Digestive symptoms are common in COVID19, occurring as the chief complaint in nearly half of patients presenting to hospital according ...
U.S. Senator Patty Murray (D-WA), ranking member of the Senate Health, Education, Labor, and Pensions (HELP) Committee has called for ...
Canon Medical Systems announced the start of development of a rapid genetic testing system for the novel coronavirus (COVID-19). This ...
Ridgeback Biotherapeutics and Drug Innovations at Emory (DRIVE) LLC, a not-for-profit biotechnology company wholly owned by Emory University, today announced ...
GenMark Diagnostics, Inc. today announced that the U.S. Food and Drug Administration (FDA) has issued Emergency Use Authorization (EUA) for ...
There’s been some confusion recently on whether we should or shouldn’t take ibuprofen to treat symptoms of COVID-19 – especially ...
Scientists should start sequencing the genomes of coronavirus patients. We should look for DNA differences between patients who are severely ...
A total of 199 patients with laboratory-confirmed SARS-CoV-2 infection underwent randomization; 99 were assigned to the lopinavir–ritonavir group, and 100 ...
Since the COVID-19 pandemic began in Wuhan, China in December 2019, we have seen the virus spread to over 160 ...